Glenmark Pharmaceuticals Limited — Clindamycin Exporter Profile
Indian Pharmaceutical Exporter · #5 for Clindamycin · $4.7M export value · DGFT Verified
Glenmark Pharmaceuticals Limited is the #5 Indian exporter of Clindamycin with $4.7M in export value and 199 verified shipments. Glenmark Pharmaceuticals Limited holds a 5.2% market share in Clindamycin exports across 6 countries. The company exports 28 pharmaceutical products worth $205.5M across 14 therapeutic categories.
Glenmark Pharmaceuticals Limited — Clindamycin Export Profile: Buyers & Destinations
Where Does Glenmark Pharmaceuticals Limited Export Clindamycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $4.2M | 192 | 91.3% |
| KAZAKHSTAN | $373.5K | 14 | 8.1% |
| UZBEKISTAN | $10.8K | 2 | 0.2% |
| BRAZIL | $8.4K | 2 | 0.2% |
| MAURITIUS | $4.9K | 2 | 0.1% |
| POLAND | $1.7K | 1 | 0.0% |
Glenmark Pharmaceuticals Limited exports Clindamycin to 6 countries. The largest destination is UNITED STATES accounting for 91.3% of Glenmark Pharmaceuticals Limited's Clindamycin shipments, followed by KAZAKHSTAN (8.1%) and UZBEKISTAN (0.2%). These destinations reflect Glenmark Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Clindamycin from Glenmark Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $1.5M | 41 |
| GLENMARK PHARMACEUTICALS INC., USA | UNITED STATES | $1.3M | 78 |
| GLENMARK PHARMACEUTICALS INC USA | UNITED STATES | $571.8K | 25 |
| GLENMARK PHARMACEUTICALS INC. USA | UNITED STATES | $283.7K | 14 |
| AMANAT LTD. | KAZAKHSTAN | $150.0K | 3 |
| GLENMARK PHARMACEUTICALS INC., USA. | UNITED STATES | $122.7K | 5 |
| GLENMARK PHARMACEUTICALS INC | UNITED STATES | $112.8K | 3 |
| GLENMARK PHARMACEUTICALS INC, USA | UNITED STATES | $104.1K | 9 |
| KPC MEDSERVICE PLUS LLP. | KAZAKHSTAN | $100.0K | 2 |
| NORTHSTAR DISTRIBUTION CENTER 8912. | UNITED STATES | $92.6K | 2 |
Glenmark Pharmaceuticals Limited supplies Clindamycin to 24 buyers globally. The largest buyer is NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES), followed by GLENMARK PHARMACEUTICALS INC., USA (UNITED STATES) and GLENMARK PHARMACEUTICALS INC USA (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Clindamycin Export Value and How Much Does Glenmark Pharmaceuticals Limited Contribute?
India exported $47.6M worth of Clindamycin through 7,242 shipments from 527 suppliers to 144 countries, serving 1,029 buyers globally. Glenmark Pharmaceuticals Limited contributes $4.7M to this total, accounting for 5.2% of India's Clindamycin exports. Glenmark Pharmaceuticals Limited ships Clindamycin to 6 countries through 24 buyers.
What Is the Average Shipment Value for Glenmark Pharmaceuticals Limited's Clindamycin Exports?
Glenmark Pharmaceuticals Limited's average Clindamycin shipment value is $23.6K per consignment, based on 199 shipments totaling $4.7M. The largest destination is UNITED STATES (91.3% of Glenmark Pharmaceuticals Limited's Clindamycin exports).
How Does Glenmark Pharmaceuticals Limited Compare to Other Indian Clindamycin Exporters?
Glenmark Pharmaceuticals Limited ranks #5 among 527 Indian Clindamycin exporters with a 5.2% market share. The top 3 exporters are ENCUBE ETHICALS PRIVATE LIMITED ($14.6M), AUROBINDO PHARMA LTD ($9.4M), GLENMARK PHARMACEUTICALS LIMITED ($4.7M). Glenmark Pharmaceuticals Limited processed 199 shipments to 6 destination countries.
What Clindamycin Formulations Does Glenmark Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CLINDAMYCIN-BPO GEL JAR 1%/5% 50GM | $401.7K | 22 |
| CLINDAMYCIN-BPO GEL JAR 1%/5% 25GM | $263.2K | 16 |
| PHARMACEUTICALS-CLINDAMYCIN PHOS GEL 1% | $245.1K | 8 |
| CLINDAMYCIN-BPO GEL PUMP 1%/5% 50GM | $174.1K | 6 |
| PHARMACEUTICALS-CLINDAMYCIN-BPO GEL JAR | $172.7K | 5 |
| CLINDAMYCIN-BPO GEL JAR 1%/5% 50GMNOS | $144.0K | 7 |
| CLINDAMYCIN PHOS GEL 1% 60GM | $116.4K | 10 |
| CLINDAMYCIN HCL CAP 150MG 100 | $112.8K | 3 |
| CLINDAMYCIN-BPO GEL JAR 1%/5% 50GM(NS) NDC CODE: 16714098450 | $112.3K | 4 |
| PHARMACEUTICALS- CLINDAMYCIN-BPO GEL JAR | $100.0K | 2 |
Glenmark Pharmaceuticals Limited exports 98 distinct Clindamycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CLINDAMYCIN-BPO GEL JAR 1%/5% 50GM with 22 shipments worth $401.7K.
Regulatory Requirements: Exporting Clindamycin to Key Markets
What Glenmark Pharmaceuticals Limited must comply with to export Clindamycin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Glenmark Pharmaceuticals Limited Compare to Nearest Clindamycin Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ENCUBE ETHICALS PRIVATE LIMITED | $14.6M | 291 | 6 | $50.0K |
| 2 | AUROBINDO PHARMA LTD | $9.4M | 188 | 2 | $50.0K |
| 5 | GLENMARK PHARMACEUTICALS LIMITED ★ | $4.7M | 199 | 6 | $23.6K |
| 3 | MICRO LABS LIMITED | $4.7M | 93 | 4 | $50.0K |
| 4 | AUROBINDO PHARMA LIMITED | $3.1M | 63 | 2 | $50.0K |
Glenmark Pharmaceuticals Limited ranks #5 among 527 Indian Clindamycin exporters. Average shipment value of $23.6K compared to the market average of $90.3K. The closest competitors by value are ENCUBE ETHICALS PRIVATE LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Clindamycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 1,184 | 16.3% |
| SAHAR AIR | 1,119 | 15.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 966 | 13.3% |
| DELHI AIR | 674 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 437 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 328 | 4.5% |
| Bombay Air | 309 | 4.3% |
| Delhi Air | 201 | 2.8% |
Geopolitical & Trade Policy Impact on Glenmark Pharmaceuticals Limited's Clindamycin Exports
Glenmark's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies like Glenmark to expand their footprint in the US market. The shifting trade dynamics have prompted US importers to seek alternative suppliers, presenting growth opportunities for Indian exporters.
The recent India-European Union Free Trade Agreement (FTA) is poised to benefit Glenmark by eliminating tariffs on pharmaceutical exports to the EU. This development enhances the company's competitiveness in the European market, potentially boosting export volumes and revenue streams. (en.wikipedia.org)
Glenmark Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Glenmark's export success. The company has consistently adhered to guidelines set by the US FDA, WHO, and EU GMP, ensuring the quality and safety of its products. Notably, Glenmark's manufacturing facilities have undergone rigorous inspections, reflecting its commitment to maintaining high-quality standards.
The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates continuous adaptation. Glenmark's proactive approach to compliance positions it well to navigate these changes, thereby sustaining its market access and reputation.
About Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited exports 28 products worth $205.5M. Beyond Clindamycin, top products include Rosuvastatin, Omeprazole, Gabapentin, Ondansetron, Naproxen. View the complete Glenmark Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clindamycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clindamycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Glenmark Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 213 individual customs records matching Glenmark Pharmaceuticals Limited exporting Clindamycin, covering 98 formulations to 6 countries via 24 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 1,029+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clindamycin Export Data from Glenmark Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Glenmark Pharmaceuticals Limited's Clindamycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Glenmark Pharmaceuticals Limited
Full Company Profile →
28 products · $205.5M total trade · 14 categories
Clindamycin Stats
Company Overview
Top Products by Glenmark Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Glenmark Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clindamycin. For current shipment-level data, contact TransData Nexus.